Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 24, 2019
Subject: Announcement of the timing for the release of financial results for the first quarter ended March 31, 2019.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice regarding the schedule for the upcoming earnings release.
Material Changes
No material changes to financial results are reported in this filing. The document announces the future disclosure of results rather than the results themselves.
Guidance, Outlook, and Management Commentary
- Earnings Release Date: After 5:00 PM ET on Tuesday, May 7, 2019.
- Conference Call: Scheduled for Wednesday, May 8, 2019, to discuss first quarter 2019 business results.
- Reference: A press release containing further details is furnished as Exhibit 99.1.
Investor Verification Checklist
- Verify the actual financial results released on or after May 7, 2019.
- Review the press release attached as Exhibit 99.1 for any additional context not included in the 8-K summary.
- Confirm attendance details for the conference call on May 8, 2019.